Metro Healthcare Bhd
Metro Healthcare Bhd operates in the healthcare sector, providing pharmaceutical and healthcare services to patients in Malaysia.
Business. Metro Healthcare Bhd (METO.KL) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding operating segments and geographic breakdowns are not provided.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Metro Healthcare Bhd (METO.KL) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding operating segments and geographic breakdowns are not provided.
Metro Healthcare Bhd has a basic and diluted share count of 978,905,000 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. This lack of financial transparency limits the ability to evaluate the company's short-term solvency or cash flow resilience.
Profitability and return metrics are not available in the valuation snapshot, making it difficult to compare the company's performance against industry benchmarks or preferred metrics for the Healthcare Facilities & Services industry. Without access to key profitability indicators such as ROIC, EBITDA margins, or net profit margins, it is not possible to assess whether the company is generating returns in line with or above the industry median.
The company's revenue concentration and geographic exposure are not disclosed in the available data, which limits the ability to evaluate the diversification of its revenue streams or the risks associated with over-reliance on specific markets or customer segments. This lack of segmental and geographic data is a material gap in understanding the company's operational resilience.
Growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or directional guidance for revenue or earnings. Without historical revenue data or forward-looking statements, it is not possible to determine whether the company is on a path of expansion, contraction, or stagnation.
Risk factors include the inability to assess liquidity risk, which is a red flag for investors seeking to understand the company's ability to meet short-term obligations. Additionally, the absence of detailed risk disclosures in source documents means that potential operational, regulatory, or market risks are not quantified or contextualized.
Recent events, including filings or transcripts, are not available in the provided data, which limits the ability to assess management's strategic direction or the company's response to external pressures. This lack of recent disclosures may indicate limited transparency or a focus on internal operations rather than public communication.
- Metro Healthcare Bhd has no immediate dilution pressure based on current share counts.
- Liquidity risk cannot be assessed due to missing balance-sheet data and lack of going-concern language.
- Profitability and return metrics are not available, making it difficult to evaluate performance against industry benchmarks.
- Revenue concentration and geographic exposure are not disclosed, limiting understanding of operational diversification.
- Growth trajectory is unclear due to the absence of numeric outlooks or historical revenue data.
- Recent events and filings are not available, reducing visibility into management's strategic direction.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue MYR 48.6M, +8,9% YoY; Operating income −15,2% YoY.
- ▍Revenue MYR 48.6M, +8,9% YoY
- ▍Operating income −15,2% YoY
- ▍Net income −27,0% YoY
- ▍Free cash flow −66,7% YoY
- ▍Net margin 9.4%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Metro Healthcare Bhd Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Tee Swi Peng TayExecutive Chairman of the Board